Impact of Collagenase Injection on Dupuytren Disease Treatment in Japan
CCH increased treatment options for patients and surgeons. The withdrawal of this valuable pharmaceutical resulted in an increase in the number of surgeries amidst a decrease in the total number of treatments and lost opportunities for patients.
Authors
- Hidemasa Yoneda (ORCID: https://orcid.org/0000-0001-8444-4941)
- Hitoshi Hirata (ORCID: https://orcid.org/0000-0001-9144-1685)
- James Curley (ORCID: https://orcid.org/0000-0002-4379-5021)
- Michiro Yamamoto (ORCID: https://orcid.org/0000-0002-6753-538X)
Institutions
- Japan Society for the Promotion of Science (JP)
- Nagoya University (JP)
- National Patient Safety Foundation (US)
Publication Details
- Journal
- Annals of Plastic Surgery
- Published
- 2024-08-12
- DOI
- https://doi.org/10.1097/sap.0000000000004076
- Citations
- 3
- Primary Topic
- Dupuytren's Contracture and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.41